ReWalk Robotics Ltd. (NASDAQ:LFWD – Get Free Report) Director Michael Swinford purchased 16,471 shares of the business’s stock in a transaction dated Wednesday, November 20th. The shares were bought at an average price of $1.84 per share, with a total value of $30,306.64. Following the purchase, the director now directly owns 26,511 shares of the company’s stock, valued at approximately $48,780.24. The trade was a 164.05 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Michael Swinford also recently made the following trade(s):
- On Monday, November 25th, Michael Swinford acquired 21,622 shares of ReWalk Robotics stock. The stock was purchased at an average cost of $2.03 per share, for a total transaction of $43,892.66.
- On Friday, November 22nd, Michael Swinford acquired 16,907 shares of ReWalk Robotics stock. The stock was purchased at an average price of $1.83 per share, with a total value of $30,939.81.
ReWalk Robotics Stock Performance
Shares of NASDAQ LFWD opened at $2.10 on Thursday. The company’s fifty day moving average is $2.54 and its two-hundred day moving average is $3.49. The firm has a market capitalization of $18.50 million, a P/E ratio of -0.84 and a beta of 2.07. ReWalk Robotics Ltd. has a one year low of $1.70 and a one year high of $9.10.
Analyst Ratings Changes
Separately, HC Wainwright reissued a “buy” rating and issued a $13.00 price target on shares of ReWalk Robotics in a report on Wednesday, November 13th.
View Our Latest Stock Report on LFWD
Institutional Investors Weigh In On ReWalk Robotics
An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP acquired a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics as of its most recent SEC filing. Hedge funds and other institutional investors own 26.76% of the company’s stock.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Stories
- Five stocks we like better than ReWalk Robotics
- Energy and Oil Stocks Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Short Selling: How to Short a Stock
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.